Segmental chromosomal aberrations and centrosome amplifications: Pathogenetic mechanisms in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma?

Leukemia

Volumn 17, Issue 11, 2003, Pages 2214-2219

  Martin Subero J I ^a   Knippschild, U ^b   Harder, L ^a   Barth, T F E ^b   Riemke, J ^a   Grohmann, S ^a   Gesk, S ^a   Hoppner J ^a   Moller P ^b   Parwaresch, R M ^a   Siebert, R ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Centrosome aberration; Chromosomal instability; Hodgkin's lymphoma; Segmental chromosomal aberration

Indexed keywords

RIBOSOME DNA;

ADULT; ARTICLE; CASE REPORT; CELL NUCLEUS; CENTROSOME; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME SEGREGATION; CHROMOSOME SIZE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE LOCUS; GENE REARRANGEMENT; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; MALE; PATHOGENESIS; PRIORITY JOURNAL; REED STERNBERG CELL;

EID: 1942544001     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403129     Document Type: Article

References (33)

1. Drexler HG. Recent results on the biology of Hodgkin and Reed-Sternberg cells. I. Biopsy material. Leuk Lymphoma 1992; 8: 283-313.
2. Deerberg-Wittram J, Weber-Matthiesen K, Schlegelberger B. Cytogenetics and molecular cytogenetics in Hodgkin's disease. Ann Oncol 1996; 7 (Suppl 4): 49-53.
3. Atkin NB. Cytogenetics of Hodgkin's disease. Cytogenet Cell Genet 1998; 80: 23-27.
4. Falzetti D, Crescenzi B, Matteuci C, Falini B, Martelli MF, Van Den Berghe H et al. Genomic instability and recurrent breakpoints are main cytogenetic findings in Hodgkin's disease. Haematologica 1999; 84: 298-305.
5. Siebert R, Rosenwald A, Staudt LM, Morris SW. Molecular features of B-cell lymphoma. Curr Opin Oncol 2001; 13: 316-324.
6. Weber-Matthiesen K, Deerberg J, Poetsch M, Grote W, Schlegelberger B. Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease. Blood 1995; 86: 1464-1468.
7. Ohshima K, Ishiguro M, Ohgami A, Sugihara M, Haraoka S, Suzumiya J et al. Genetic analysis of sorted Hodgkin and Reed-Sternberg cells using comparative genomic hybridization. Int J Cancer 1999; 82: 250-255.
8. Joos S, Küpper M, Ohl S, von Bonin F, Mechtersheimer G, Bentz M et al. Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res 2000; 60: 549-552.
9. MacLeod RA, Spitzer D, Bar-Am I, Sylvester JE, Kaufmann M, Wernich A et al. Karyotypic dissection of Hodgkin's disease cell lines reveals ectopic subtelomeres and ribosomal DNA at sites of multiple jumping translocations and genomic amplification. Leukemia 2000; 14: 1803-1814.
10. Küpper M, Joos S, von Bonin F, Daus H, Pfreundschuh M, Lichter P et al. MDM2 gene amplification and lack of p53 point mutations in Hodgkin and Reed-Sternberg cells: results from single-cell polymerase chain reaction and molecular cytogenetic studies. Br J Haematol 2001; 112: 768-775.
11. Joos S, Menz CK, Wrobel G, Siebert R, Gesk S, Ohl S et al. Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood 2002; 99: 1381-1387.
12. Martin-Subero JI, Gesk S, Harder L, Sonoki T, Tucker PW, Schlegelberger B et al. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood 2002; 99: 1474-1477.
13. Joos S, Granzow M, Holtgreve-Grez H, Siebert R, Harder L, Martin-Subero JI et al. Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2. Int J Cancer 2003; 103: 489-495.
14. Berglund M, Flordal E, Gullander J, Lui WO, Larsson C, Lagercrantz S et al. Molecular cytogenetic characterization of four commonly used cell lines derived from Hodgkin lymphoma. Cancer Genet Cytogenet 2003; 141: 43-48.
15. Barth TF, Martin-Subero JI, Joos S, Menz CK, Hasel C, Mechtersheimer G et al. Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin's lymphoma. Blood 2003; 101: 3681-3686.
16. Tanaka K, Arif M, Eguchi M, Kyo T, Dohy H, Kamada N. Frequent jumping translocations of chromosomal segments involving the ABL oncogene alone or in combination with CD3-MLL genes in secondary leukemias. Blood 1997; 89: 596-600.
17. Tanaka K, Kamada N. Segmental jumping translocation in leukemia and lymphoma with a highly complex karyotype. Leuk Lymphoma 1998; 29: 563-575.
18. Lejeune J, Maunoury C, Prieur M, Van den Akker J. Translocation sauteuse (5p;15q), (8q;15q), and (12q;15q). Ann Genet 1979; 22: 210-213.
19. Cuthbert G, McCullough S, Finney R, Breese G, Bown N. Jumping translocation at 11q23 with MLL gene rearrangement and interstitial telomeric sequences. Genes Chromosomes Cancer 1999; 24: 295-298.
20. Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P et al. Centrosome defects and genetic instability in malignant tumors. Cancer Res 1998; 58: 3974-3985.
21. Nigg EA. Centrosome aberrations: cause or consequence of cancer progression? Nat Rev Cancer 2002; 2: 815-825.
22. Krämer A, Neben K, Ho AD. Centrosome replication, genomic instability and cancer. Leukemia 2002; 16: 767-775.
23. Fukasawa K. Introduction: centrosome. Oncogene 2002; 21: 6140-6145.
24. Neben K, Giesecke C, Schweizer S, Ho AD, Krämer A. Centrosome aberrations in acute myeloid leukemia are correlated with cytogenetic risk profile. Blood 2003; 101: 289-291.
25. Schlegelberger B, Metzke S, Harder S, Zühlke-Jenisch R, Zhang Y, Siebert R. Classical, molecular cytogenetics of tumor cells. In: Wegner R (ed). Diagnostic Cytogenetics. New York: Springer-Verlag, 1999 pp 151-185.
26. Martin-Subero JI, Chudoba I, Harder L, Gesk S, Grote W, Novo FJ et al. Multicolor-FICTION: expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses. Am J Pathol 2002; 161: 413-420.
27. Page SL, Shin JC, Han JY, Choo KH, Shaffer LG. Breakpoint diversity illustrates distinct mechanisms for Robertsonian translocation formation. Hum Mol Genet 1996; 5: 1279-1288.
28. Kolomietz E, Meyn MS, Pandita A, Squire JA. The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors. Genes Chromosomes Cancer 2002; 35: 97-112.
29. Pihan GA, Purohit A, Wallace J, Malhotra R, Liotta L, Doxsey SJ. Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. Cancer Res 2001; 61: 2212-2219.
30. Herrmann L, Dittmar T, Erdmann KS. The protein tyrosine phosphatase PTP-BL associates with the midbody and is involved in the regulation of cytokinesis. Mol Biol Cell 2003; 14: 230-240.
31. Rios RM, Bornens M. The Golgi apparatus at the cell centre. Curr Opin Cell Biol 2003; 15: 60-66.
32. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 1998; 20: 189-193.
33. Meraldi P, Honda R, Nigg EA. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J 2002; 21: 483-492.